Cargando…

Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units

BACKGROUND: Little information is available on current practice in beta-lactam dosing during continuous renal replacement therapy (CRRT). Optimized dosing is essential for improving outcomes, and there is no consensus on the appropriate dose regimens. The objective of the present study was to descri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matusik, Elodie, Lemtiri, Justine, Wabont, Guillaume, Lambiotte, Fabien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800323/ https://www.ncbi.nlm.nih.gov/pubmed/35093011 http://dx.doi.org/10.1186/s12882-022-02678-x

Ejemplares similares

Commentary: Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
por: Matusik, Elodie
Publicado: (2020)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

Fosfomycin-induced agranulocytosis: a case report and review of the literature
por: Matusik, Elodie, et al.
Publicado: (2023)

Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?
por: De Waele, Jan J, et al.
Publicado: (2014)

The role of the critical care pharmacist during the COVID-19 pandemic
por: Lemtiri, J., et al.
Publicado: (2020)

Renal replacement therapy does have impact on beta-lactam clearance
por: Yu, Zhenwei
Publicado: (2023)

β-lactam antibiotic concentrations during continuous renal replacement therapy
por: Beumier, Marjorie, et al.
Publicado: (2014)

Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity
por: Legg, Amy, et al.
Publicado: (2023)

Prise en charge COVID-19 au sein des soins critiques du plus important centre hospitalier général de France: Comment la coordination urgences, réanimation et anesthésie a permis de gérer avec succès l’épidémie de coronavirus sur le territoire valenciennois ?
por: Defrancq, Fanny, et al.
Publicado: (2020)

Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?
por: Roger, Claire, et al.
Publicado: (2021)

Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
por: Seyler, Lucie, et al.
Publicado: (2011)

Dosing patterns for continuous renal replacement therapy in the United States
por: Venkataraman, R, et al.
Publicado: (2001)

Beta-lactam antibiotics in continuous infusion in critically ill patients
por: Jeurissen, Axel, et al.
Publicado: (2010)

Beta-lactam antibiotic test doses in the emergency department
por: Maguire, Michelle, et al.
Publicado: (2020)

Beta-lactam allergy labeling in intensive care units: An observational, retrospective study
por: Leone, Marc, et al.
Publicado: (2021)

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
por: Abdul-Aziz, Mohd H, et al.
Publicado: (2012)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

Echocardiographic parameters of patients in the intensive care unit undergoing continuous renal replacement therapy
por: Kompotiatis, Panagiotis, et al.
Publicado: (2019)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Lacosamide dosing in patients receiving continuous renal replacement therapy
por: Chaijamorn, Weerachai, et al.
Publicado: (2023)

Management of renal replacement therapy among adults in French intensive care units: A bedside practice evaluation
por: Jolly, Florian, et al.
Publicado: (2023)

Antimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies
por: Kempke, Anna P., et al.
Publicado: (2016)

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
por: Van Herendael, Bruno, et al.
Publicado: (2012)

Articulation des pharmaciens (cliniciens dans les services et à la pharmacie à usage intérieur) au service du patient de réanimation en période de pandémie à SARS-CoV-2
por: Lemtiri, J., et al.
Publicado: (2022)

Impact of renal replacement therapy strategy on beta-lactam plasma concentrations: the BETAKIKI study—an ancillary study of a randomized controlled trial
por: Roux, Damien, et al.
Publicado: (2023)

2545. Impact of Early Dose Adjustment of Beta-Lactams in Patient with Septic Shock
por: Tawwater, John C, et al.
Publicado: (2023)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

Distinction between induction and maintenance dosing in continuous renal replacement therapy
por: MacLaren, Graeme
Publicado: (2011)

Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
por: Li, Lu, et al.
Publicado: (2020)

Genetic associations in beta-lactam allergy
por: Gueant, Jean-Louis, et al.
Publicado: (2014)

Endopeptidase-Mediated Beta Lactam Tolerance
por: Dörr, Tobias, et al.
Publicado: (2015)

Profile of Enterobacteria Resistant to Beta-Lactams
por: Santos, Andressa Liberal, et al.
Publicado: (2020)

Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the ‘Maximum Tolerable Dose’
por: Dhaese, Sofie A. M., et al.
Publicado: (2022)

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation
por: Bakdach, Dana, et al.
Publicado: (2022)

Renal replacement therapy in adult and pediatric intensive care: Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD)
por: Vinsonneau, Christophe, et al.
Publicado: (2015)

Variation in Target Attainment of Beta‐Lactam Antibiotic Dosing Between International Pediatric Formularies
por: Gastine, Silke, et al.
Publicado: (2021)

Continuous renal replacement therapy in intensive care patients with COVID-19; survival and renal recovery
por: Eriksson, Karin E., et al.
Publicado: (2021)

Renal replacement therapy in the intensive care unit
por: Pannu, Neesh, et al.
Publicado: (2005)

Renal replacement therapy in the intensive care unit
por: Chacko, Jose
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_12j7jq8j6l47orcorokl0vbeka